Division of Genetics, Regional Medical Research Centre for Tribals (ICMR), Nagpur Road, PO-Garha, Jabalpur-482003, Madhya Pradesh, INDIA.
Mediterr J Hematol Infect Dis. 2015 Jul 2;7(1):e2015046. doi: 10.4084/MJHID.2015.046. eCollection 2015.
Oxidative stress constitutes one of the significant cause of vaso-occlusive clinical episodes in sickle cell disease (SCD) patients. It brings about the generation of reactive oxygen species and consequent damage to DNA. DNA damage repair genes such as hOGG1, XRCC1 and p53 play an important role in the repair of DNA damage during oxidative stress. However, it is not known as to the role of these genes in oxidative stress mediated vaso-occlusive clinical complications of SCD patients.
To see the possible association of DNA repair gene polymorphisms with clinical manifestation of SCD patients.
Genotyping of DNA damage repair genes by PCR-RFLP, measurement of oxidant and anti-oxidant status, along with a clinical evaluation of 250 SCD patients and their comparison with normal individuals.
The level of oxidants were high, and that of antioxidants were low in SCD patients compared to normal individuals. The prevalence of mutant alleles of hOGG1 gene, XRCC1 gene (codon 280 Arg>His) were found to be significantly higher among SCD patients as compared to controls. However, SCD patients did not show clinical association with any of these DNA repair gene polymorphisms.
This indicates that hOGG1, p53and XRCC1 gene polymorphisms have no clinical association with SCD patients in India.
氧化应激是导致镰状细胞病(SCD)患者血管阻塞性临床发作的重要原因之一。它会导致活性氧的产生,并导致 DNA 损伤。DNA 损伤修复基因,如 hOGG1、XRCC1 和 p53,在氧化应激过程中 DNA 损伤的修复中起着重要作用。然而,这些基因在氧化应激介导的 SCD 患者血管阻塞性临床并发症中的作用尚不清楚。
探讨 DNA 修复基因多态性与 SCD 患者临床表现的可能相关性。
采用 PCR-RFLP 技术对 DNA 损伤修复基因进行基因分型,检测氧化应激和抗氧化状态,并对 250 例 SCD 患者进行临床评估,并与正常个体进行比较。
与正常个体相比,SCD 患者的氧化剂水平较高,抗氧化剂水平较低。与对照组相比,SCD 患者 hOGG1 基因、XRCC1 基因(密码子 280 Arg>His)的突变等位基因的发生率明显更高。然而,SCD 患者的这些 DNA 修复基因多态性与任何临床表型均无关联。
这表明 hOGG1、p53 和 XRCC1 基因多态性与印度 SCD 患者无临床相关性。